Dustin Baldridge, MD, PhD, an assistant professor of pediatrics at Washington University School of Medicine in St. Louis, has received a 2023 Avenir Award in Genetics and Epigenetics of Substance Use from the National Institute on Drug Abuse (NIDA). The award is given to early-career scientists proposing highly innovative studies and showing promise of being leaders in the field of addiction science. The grant is expected to provide $2.3 million over five years.
Baldridge is one of three awardees selected this year for the Avenir Award in Genetics and Epigenetics of Substance Use. A pediatrician, he conducts translational genomics research and serves as a co-investigator for the Washington University Model Organism Screening Center of the Undiagnosed Diseases Network.
Read more on the School of Medicine website.
Comments and respectful dialogue are encouraged, but content will be moderated. Please, no personal attacks, obscenity or profanity, selling of commercial products, or endorsements of political candidates or positions. We reserve the right to remove any inappropriate comments. We also cannot address individual medical concerns or provide medical advice in this forum.